MedTrace Logo

Digital Behavioral Interventions in Inflammatory Bowel Disease

NCT04861597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

Given the bidirectionality between psychological distress and disease activity in inflammatory bowel disease (IBD), whereby increased psychological distress exacerbates disease activity and vice versa, psychosocial aspects of IBD care are receiving increased attention. However, proposed interventions are generally resource-intensive and have been tested in majority white populations. While people of color are an increasing segment of the IBD population, they are currently underrepresented in research studies. The purpose of this study is to evaluate the efficacy and implementation of internet-based cognitive behavioral therapy (iCBT) among IBD patients of color with elevated psychological distress.

Conditions

  • Crohn Disease
  • Ulcerative Colitis
  • Inflammatory Bowel Diseases
  • Stress, Psychological
  • Depression, Anxiety

Interventions

BEHAVIORAL

Internet based cognitive behavioral therapy

Participants with elevated psychological distress will receive 8 weeks of internet-based cognitive behavioral therapy

BEHAVIORAL

Digital mood tracking

Participants with elevated psychological distress will receive 8 weeks of digital mood tracking

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Ruby Greywoode, MD · Montefiore Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-03-22
Completion
2023-03-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861597 on ClinicalTrials.gov